BioMedPartners and BB Pureos Bioventures have co-led a CHF 12.5m series-A for biotechnology company Alentis Therapeutics.
Italian mid-market firm Progressio held an interim close on €185m back in February
Fresh capital will support product innovation and European expansion for the Spanish startup
Outsourced drug development company has expanded into the US and tripled its revenues under GHO
GP buys majority in Netherlands-based software testing and quality assurance specialist